Emmanouil Spanakis

Dr. Emmanouil Spanakis

Computational BioMedicine Laboratory, Institute of Computer Science, Foundation for Research and Technology – HELLAS, Nikolaou Plastira 100, Vassilika Vouton, P.O Box 1385, GR-70013 Heraklion, Crete, Greece
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Emmanouil SpanakisEmmanouil Spanakis
Emmanouil Spanakis
SSSilvina Santana
Silvina Santana
Manolis TsiknakisManolis Tsiknakis
Manolis Tsiknakis
Kostas MariasKostas Marias
Kostas Marias
Vangelis SakkalisVangelis Sakkalis
Vangelis Sakkalis
CTChariklia Tziraki-Segal
Chariklia Tziraki-Segal
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

4 October 2012 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
Emmanouil SpanakisEmmanouil Spanakis
Emmanouil Spanakis
FCFranco Chiarugi
Franco Chiarugi
AKAngelina Kouroubali
Angelina Kouroubali
SSStephan Spat
Stephan Spat
PBPeter Beck
Peter Beck
JTJesper Thestrup
Jesper Thestrup
Diabetes Management Using Modern Information and Communication Technologies and New Care Models

9 April 2021 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
Emmanouil SpanakisEmmanouil Spanakis
Emmanouil Spanakis
SSStelios Sfakianakis
Stelios Sfakianakis
SBSilvia Bonomi
Silvia Bonomi
CCClaudio Ciccotelli
Claudio Ciccotelli
SMSabina Magalini
Sabina Magalini
VSVangelis Sakkalis
Vangelis Sakkalis
This work aims to provide information, guidelines, established practices and standards, and an extensive evaluation on new and promising technologies for the implementation of a secure information sharing platform for health-related data. We focus strictly on the technical aspects and specifically on the sharing of health information, studying innovative techniques for secure information sharing within the health-care domain, and we describe our solution and evaluate the use of blockchain methodologically for integrating within our implementation. To do so, we analyze health information sharing within the concept of the PANACEA project that facilitates the design, implementation, and deployment of a relevant platform. The research presented in this paper provides evidence and argumentation toward advanced and novel implementation strategies for a state-of-the-art information sharing environment; a description of high-level requirements for the transfer of data between different health-care organizations or cross-border; technologies to support the secure interconnectivity and trust between information technology (IT) systems participating in a sharing-data “community”; standards, guidelines, and interoperability specifications for implementing a common understanding and integration in the sharing of clinical information; and the use of cloud computing and prospectively more advanced technologies such as blockchain. The technologies described and the possible implementation approaches are presented in the design of an innovative secure information sharing platform in the health-care domain.

16 February 2019 in Medicines
Verified
Journal Article
Open access
PDF file
Marios SpanakisMarios Spanakis
Marios Spanakis
SSStelios Sfakianakis
Stelios Sfakianakis
Vangelis SakkalisVangelis Sakkalis
Vangelis Sakkalis
Emmanouil SpanakisEmmanouil Spanakis
Emmanouil Spanakis
Herbal medicinal products (HMPs) are the subject of increasing interest regarding their benefits for health. However, a serious concern is the potential appearance of clinically significant drug–herb interactions in patients. This work provides an overview of drug–herb interactions and an evaluation of their clinical significance. We discuss how personalized health services and mobile health applications can utilize tools that provide essential information to patients to avoid drug–HMP interactions. There is a specific mention to PharmActa, a dedicated mobile app for personalized pharmaceutical care with information regarding drug–HMPs interactions. Several studies over the years have shown that for some HMPs, the potential to present clinically significant interactions is evident, especially for many of the top selling HMPs. Towards that, PharmActa presents how we can improve the way that information regarding potential drug–herb interactions can be disseminated to the public. The utilization of technologies focusing on medical information and context awareness introduce a new era in healthcare. The exploitation of eHealth tools and pervasive mobile monitoring technologies in the case of HMPs will allow the citizens to be informed and avoid potential drug–HMPs interactions enhancing the effectiveness and ensuring safety for HMPs.

24 March 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
ETEleftheria Tzamali
Eleftheria Tzamali
Vangelis SakkalisVangelis Sakkalis
Vangelis Sakkalis
GTGeorgios Tzedakis
Georgios Tzedakis
Emmanouil SpanakisEmmanouil Spanakis
Emmanouil Spanakis
NTNikos Tzanakis
Nikos Tzanakis
The regulation policies implemented, the characteristics of vaccines, and the evolution of the virus continue to play a significant role in the progression of the SARS-CoV-2 pandemic. Numerous research articles have proposed using mathematical models to predict the outcomes of different scenarios, with the aim of improving awareness and informing policy-making. In this work, we propose an expansion to the classical SEIR epidemiological model that is designed to fit the complex epidemiological data of COVID-19. The model includes compartments for vaccinated, asymptomatic, hospitalized, and deceased individuals, splitting the population into two branches based on the severity of progression. In order to investigate the impact of the vaccination program on the spread of COVID-19 in Greece, this study takes into account the realistic vaccination program implemented in Greece, which includes various vaccination rates, different dosages, and the administration of booster shots. It also examines for the first time policy scenarios at crucial time-intervention points for Greece. In particular, we explore how alterations in the vaccination rate, immunity loss, and relaxation of measures regarding the vaccinated individuals affect the dynamics of COVID-19 spread. The modeling parameters revealed an alarming increase in the death rate during the dominance of the delta variant and before the initiation of the booster shot program in Greece. The existing probability of vaccinated people becoming infected and transmitting the virus sets them as catalytic players in COVID-19 progression. Overall, the modeling observations showcase how the criticism of different intervention measures, the vaccination program, and the virus evolution has been present throughout the various stages of the pandemic. As long as immunity declines, new variants emerge, and vaccine protection in reducing transmission remains incompetent; monitoring the complex vaccine and virus evolution is critical to respond proactively in the future.

1 October 2019
Verified
Conference Paper
Closed access
CFCristina Farmaki
Cristina Farmaki
MKMyrto Krana
Myrto Krana
MPMatthew Pediaditis
Matthew Pediaditis
Emmanouil SpanakisEmmanouil Spanakis
Emmanouil Spanakis
VSVangelis Sakkalis
Vangelis Sakkalis
Brain computer interfaces (BCIs) that are focused on navigation applications have been developed for patients suffering from severe paralysis to offer a means of autonomy. In SSVEP-based BCIs, users focus their gaze on flickering targets, which correspond to specific commands. Besides the accuracy of the target identification, several additional aspects are important for the development of a practical and useful BCI, such as low cost, ease of use and robustness to everyday-life conditions. In a previous paper, we presented an SSVEP-based BCI for remote robotic car navigation offering live camera feedback. In this paper, we further improve our implementation by adding a fourth direction (backwards), while redeveloping the software in a free-license environment (Python) using a smaller and lighter robotic car, easier to maneuver in interior spaces. Additionally, we study the possibility of using a single channel EEG and test the performance of our system in an offline session, as well as in an online realistic navigation in a predefined remote route. A total of 14 participants achieved an average offline accuracy of 81%, an average offline ITR of 117.1 bits/min and an average online completion time ratio (BCI completion time against optimal button completion time) of 2.27. All of the participants managed to finish the route under realistic conditions which indicates that our system has the potential to be integrated in the everyday life of immobilized patients.